Enzo Biochem Files Q3 2025 10-Q

Enzo Biochem Inc 10-Q Filing Summary
FieldDetail
CompanyEnzo Biochem Inc
Form Type10-Q
Filed DateMar 17, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, healthcare

TL;DR

Enzo Biochem filed its 10-Q for Jan 31, 2025. Check financials.

AI Summary

Enzo Biochem, Inc. filed its quarterly report on Form 10-Q for the period ended January 31, 2025. The company, incorporated in New York, operates in the medical laboratories sector. Its principal executive offices are located at 21 Executive Blvd, Farmingdale, New York. The filing details its financial performance and operational status for the specified quarter.

Why It Matters

This filing provides investors with an update on Enzo Biochem's financial health and operational progress for the third quarter of fiscal year 2025, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a publicly traded company filing regular financial reports, Enzo Biochem faces inherent market and operational risks that are detailed within its SEC filings.

Key Players & Entities

  • ENZO BIOCHEM INC (company) — Registrant
  • January 31, 2025 (date) — Quarterly period end date
  • 20250317 (date) — Filing date
  • 001-09974 (dollar_amount) — Commission File Number
  • New York (location) — State of Incorporation
  • 21 Executive Blvd . Farmingdale , New York 11735 (location) — Address of Principal Executive office
  • 13-2866202 (dollar_amount) — IRS Employer Identification No.

FAQ

What is the reporting period for this 10-Q filing?

The quarterly period ended January 31, 2025.

What is the company's full name as specified in its charter?

The company's full name is ENZO BIOCHEM, INC.

In which state was Enzo Biochem, Inc. incorporated?

Enzo Biochem, Inc. was incorporated in New York.

What is the address of Enzo Biochem's principal executive office?

The address of Enzo Biochem's principal executive office is 21 Executive Blvd, Farmingdale, New York 11735.

What is the Commission File Number for Enzo Biochem, Inc.?

The Commission File Number for Enzo Biochem, Inc. is 001-09974.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on March 17, 2025 regarding ENZO BIOCHEM INC.

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.